NCT04986293
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +19 more
- Locations
-
- University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
Clinical trial condition
Malignant Lymphoma
Explore clinical trials studying Malignant Lymphoma. Study availability and eligibility vary by location and protocol.
19 public trials
1 recruiting study
Malignant Lymphoma trial results
NCT06358001
- Conditions
- Adenocarcinoma, Autoimmune Diseases, Autoimmune Pancreatitis, +34 more
- Locations
-
- University of California, Irvine Orange, California, United States
- Advent Health, Porter Denver, Colorado, United States
- Shands Hospital-University of Florida Gainesville, Florida, United States
- University of Florida Shands Hospital Gainesville, Florida, United States
NCT03346096
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Chaim Sheba Medical Center Ramat Gan, Israel
NCT05827341
- Conditions
- COVID-19, Clinical Trial, Coronaviridae Infections, +19 more
- Locations
-
- Department of Medical Oncology, Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
Completed
Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma
NCT05190263
- Conditions
- Anemia, Anemia, Hypochromic, Anemia, Iron Deficiency, +16 more
- Locations
-
- Studienzentrum Prof. Dr. med. Hartmut Link, Facharzt für Innere Medizin, Hämatologie und Internistische Onkologie Kaiserslautern, Germany
NCT04760184
- Conditions
- Blood Protein Disorders, COVID-19, Cardiovascular Diseases, +32 more
- Locations
-
- Uppsala Universitet Uppsala, Sweden
NCT03316144
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
NCT04464590
- Conditions
- Diagnostic Imaging, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
Not specified
Completed
Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
NCT01324323
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +10 more
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Canon Research Institute Nashville, Tennessee, United States
- Sarah Cannon Research UK London, United Kingdom
Completed
Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
NCT01324310
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +10 more
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Sarah Cannon Research UK London, United Kingdom